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Neurobiology of Disease
-Secretase Composed of PS1/Pen2/Aph1a Can Cleave Notch
and Amyloid Precursor Protein in the Absence of Nicastrin
Guojun Zhao,1 Zhenyi Liu,1Ma. Xenia G. Ilagan,1 and Raphael Kopan1,2
1Department of Developmental Biology, and 2Division of Dermatology, Washington University School of Medicine, St. Louis, Missouri 63110
-Secretase is a multiprotein, intramembrane-cleaving protease with a growing list of protein substrates, including the Notch receptors
and the amyloid precursor protein. The four components of -secretase complex—presenilin (PS), nicastrin (NCT), Pen2, and Aph1—
are all thought to be essential for activity. The catalytic domain resides within PS proteins, NCT has been suggested to be critical for
substrate recognition, and the contributions of Pen2 and Aph1 remain unclear. The role of NCT has been challenged recently by the
observation that a critical residue (E332) in NCT, which had been thought to be essential for -secretase activity, is instead involved in
complex maturation. Here, we report that NCT is dispensable for -secretase activity. NCT-independent -secretase activity can be
detected in two independent NCT-deficient mouse embryonic fibroblast lines and blocked by the -secretase inhibitors N-[N-(3,5-
difluorophenacetyl-L-alanyl)]-S-phenylglycine t-butyl ester and L-685,458. This catalytic activity requires prior ectodomain sheddingof the
substrate and can cleave ligand-activated endogenous Notch receptors, indicating presence of this activity at the plasma membrane. Small
interfering RNA knockdown experiments demonstrated that NCT-independent -secretase activity requires the presence of PS1, Pen2, and
Aph1a but can tolerate knockdown of PS2 or Aph1b. We conclude that a PS1/Pen2/Aph1a trimeric complex is an active enzyme, displaying
biochemical properties similar to those of-secretase and roughly 50%of its activitywhennormalized to PS1N-terminal fragment levels. This
PS1/Pen2/Aph1a complex, however, is highly unstable. Thus, NCT acts to stabilize-secretase but is not required for substrate recognition.
Introduction
-Secretase is a multiprotein, intramembrane-cleaving protease
that cleaves its substrates within their transmembrane domains
(TMDs) (Selkoe and Kopan, 2003). Biologically and clinically
important -secretase substrates (Fagan et al., 2007; Selkoe and
Wolfe, 2007; Dejaegere et al., 2008) include amyloid precursor
protein (APP) (Haass, 2004; Thinakaran and Koo, 2008; Wolfe,
2008), ErbB4 (Ni et al., 2001), neuregulin (Bao et al., 2003), and
the Notch receptors (De Strooper et al., 1999). The physiological
and pathological roles of -secretase, its potential as a drug target
in cancer and Alzheimer’s disease (Miele et al., 2006; Roy et al.,
2007; Aster et al., 2008; Tomita, 2009), and its novel function as
an intramembrane-cleaving protease have generated intense
commercial and academic interest in this mysterious enzyme. A
better understanding of its structure, substrate recognition, and
regulation will improve therapeutic exploitation of this complex
protease (Kukar et al., 2008; Wolfe, 2009).
Genetic and biochemical studies have provided strong evi-
dence that -secretase is a multiprotein complex comprised of
presenilin (PS; either PS1 or PS2), which contains the catalytic
site (De Strooper et al., 1998; Wolfe et al., 1999; Li et al., 2000);
nicastrin (NCT), which is thought to contain a substrate binding
site (Shah et al., 2005); and Pen2 and Aph1 (1a, 1b, or 1c in
rodents), which are of unclear contribution (De Strooper, 2003;
Iwatsubo, 2004). Loss of any of these four proteins seemed to
abolish -secretase activity (Francis et al., 2002; Takasugi et al.,
2003), and only coexpression of the four components together
reconstitutes -secretase activity in yeast (Edbauer et al., 2003) or
SF9 cells (Hayashi et al., 2004), both of which lack endogenous
-secretase activity. Consistent with the existence of several dis-
tinct -secretases, the active enzyme contains four components,
each with potentially unique properties (Serneels et al., 2009).
PS is the founding member of a novel GxGD-type aspartyl
protease family that includes the prokaryotic type IV prepilin
peptidase (TFPP) and the eukaryotic signal peptide peptidase
(SPP) and SPP-like proteases (SPPLs) (Haass and Steiner, 2002).
In contrast to PS, TFPP, SPP, and SPPL proteins are single-chain
enzymes, performing their activity without additional partners
(Golde et al., 2009; Wolfe, 2009). It is still unclear why PS needs
several cofactors. The precise role for NCTwithin -secretase has
been controversial. NCT may facilitate substrate recognition
(Shah et al., 2005; Dries et al., 2009) ormay instead act to stabilize
the -secretase complex (Shirotani et al., 2004; Zhang et al.,
2005); a critical residue thought to be involved in substrate rec-
ognition (E332) was shown to be essential for -secretase matu-
ration but not for its activity in mouse cells (Chavez-Gutierrez et
al., 2008). Thus, the exact role of NCT remains controversial.
To elucidate the contribution of NCT to -secretase, we ana-
lyzed-secretase activity in two independentNCT knock-out cell
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lines.We found that a complex containing PS1, Pen2, and Aph1a
could cleave Notch and APP at the same sites used by holo--
secretase. The presence of catalytic activity demonstrated un-
equivocally that NCT is not required for -secretase substrate
recognition, instead acting mainly to stabilize -secretase.
Materials andMethods
Plasmids. pCS2/N1E-6MT, pCS2/C99-6MT, and pcDNA3/PS1wt
vectors have been described previously (Kopan et al., 1996; Schroeter et
al., 2003).
Cell lines. NCT-deficient Ncstn tm1Pcw/Ncstn tm1Pcw (NCTPW
/)
and wild-type (NCTPW
/) mouse embryonic fibroblast (MEF) lines
were generous gifts fromDr. Philip C.Wong (JohnsHopkins University,
Baltimore, MD) (Li et al., 2003). PS1/PS2 double knock-out (PSDKO)
and PS1/PS2 wild-type (PS/) MEF lines were generous gifts from Dr.
Bart De Strooper (Katholieke Universiteit Leuven, Leuven, and Flanders
Institute for Biotechnology, Leuven, Belgium) (Herreman et al., 1999).
We established Ncstn tm1Rroz/ Ncstn tm1Rroz MEF using NCT/ breeders
generously provided by Dr. Richard Rozmahel (University of Toronto,
Toronto, Canada) (Nguyen et al., 2006) using a previously described
method (Li et al., 2003) butwith a slightmodification. Briefly, embryonic
day (E)9.5 embryos wereminced and resuspended in DMEM containing
0.025% trypsin/EDTA and incubated at 37°C for 20 min. DMEM sup-
plemented with 10% fetal bovine serum (FBS)
was added to neutralize the trypsin/EDTA, and
the cells were further dissociated by pipetting,
plated into 24-well plates, and subsequently im-
mortalized with polyoma large T antigen. Im-
mortalized NCT knock-out clones were
confirmed by both genotyping andWestern blot
analysis.
Cell culture and plasmid transfection. For
most experiments, cells were maintained in
DMEM supplemented with 10% FBS, 2 mM
glutamine and incubated at 37°C and 5%CO2.
To examine the generation of Notch intracel-
lular domain (NICD) and amyloid intracellu-
lar domain (AICD), cells were transfected with
pCS2/N1E-6MT and pCS2/C99-6MT
vectors or empty vector using Lipofectamine
2000 (Invitrogen) or FuGENE HD (Roche)
transfection reagents, according to the manu-
facturers’ instructions. The transfected cells
were subsequently cultured in the presence or
absence of proteasome inhibitors (4.5 M lac-
tacystin/0.15 M MG262; Calbiochem) and
-secretase inhibitors [either 1 M N-[N-(3,5-
difluorophenacetyl-L-alanyl)]-S-phenylglycine
t-butyl ester (DAPT) or 1 M L-685,458;
Calbiochem].
A analysis. pCS2/C99-6MT-transfected
cells were cultured in OPTI-MEM supple-
mented with 7% FBS, 2 mM glutamine, 10 mM
nonessential amino acids, 10M phosphoram-
idon disodium (Sigma), with or without pro-
teasome inhibitors and -secretase inhibitors.
Both cells and conditioned media (CMs) were
collected 20–22 h later. The CMs were supple-
mented with 1 mM AEBSF [4-(2-aminoethyl)
benzenesulfonyl fluoride hydrochloride; Roche],
centrifuged, and analyzed by A ELISA (In-
vitrogen) according to the manufacturer’s in-
structions, but with a slight modification. The
incubation time for antibodies and stabilized
chromogen and the time for each wash step
were increased to make testing lower levels of
Amore accurate. Each sample was run in du-
plicate. The CMs from cells transfected with
empty vector were used as blanks.
Coculture of NCTRR
/ cells with ligand-expressing cells. NCTRR
/ or
PSDKO cells were coseeded with either CHO-DLL1-IRES-GFP (CHO:
Chinese hamster ovary; IRES: internal ribosome entry site; GFP: green
fluorescent protein) or CHO-GFP control cells (these two cell lines have
been described previously) (Ong et al., 2008), cultured for 24 h, and then
treated with or without lactacystin/MG262 and DAPT. The cells were
collected after 20 h and lysed with lysis buffer A containing 8 M urea, 1%
SDS, 50mM Tris-HCl, pH 6.8, 2 mM EDTA, 2mMDTT, and 1 protease
inhibitor cocktail (Roche) (Zhao et al., 2004).
siRNA transfection. ON-TARGETplus small interfering RNA (siRNA)
smart pools targeting mouse PS1, PS2, Pen2, Aph1a, and Aph1b were
purchased from Dharmacon (see supplemental Table 1, available at
www.jneurosci.org as supplemental material for sequences). ON-
TARGETplus nontargeting siRNA control (Dharmacon) was used as a neg-
ative control. siRNAs were transfected into NCT/ cells using
DharmaFect 1 (Dharmacon) according to the manufacturer’s in-
structions. The cells were cultured in complete medium for 48 h and
then transfected with pCS2/N1E-6MT vector. Knockdown effi-
ciency was determined by either Western blotting or quantitative
reverse transcription (qRT)-PCR.
qRT-PCR. siRNA-transfected NCTRR
/ cells were cultured for 68 h.
The total RNA was then isolated using RNeasy Micro kit (Qiagen) ac-
cording to themanufacturer’s instructions. The reverse transcriptionwas
Figure 1. NICD is generated by a GSI-sensitive activity in NCT/ cells but not in PS DKO cells. RepresentativeWestern blots of
NICD levels in pCS2/N1E-6MT-transfectedNCTPW
/, NCTPW
/, and PS DKO cells are shown.A, Schematic representation of
Notch C-terminal fragments (CTFs). TMIC (transmembrane/intracellular), NEXT, and NICD denote Notch CTFs generated after S1,
S2, and S3 site cleavages, respectively. B, Cells were transiently transfected with pCS2/N1E-6MT or pCS2 empty vector.
N1E-6MT does not contain the extracellular domain, thereby making it a ligand-independent, direct substrate of -secretase.
NICD accumulated in both NCTPW
/ and NCTPW
/ cells cultured in the presence of proteasome inhibitors (lactacystin/MG262)
but not in PS DKO cells; DAPT and L-685,458 blockedNICDgeneration. NCTmandNCTimdenotemature and immature forms of NCT,
respectively. FL-PS1, Full-length PS1.
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performed using SuperScript II reverse tran-
scriptase (Invitrogen) with oligo(dT)16 as the
primer. Quantitative PCR was performed ac-
cording to previously described methods
(Lee et al., 2007) (see supplemental Table 2,
available at www.jneurosci.org as supple-
mental material for primer sequences).
EDTA treatment. NCTRR
/, NCTPW
/,
PSDKO, and PS/ cells were washed once with
HBSS buffer (without Ca or Mg) and incu-
bated in 1.5mM EDTA/HBSS buffer for 40min
at 37°C. For -secretase inhibition, cells were
treated with 1 M DAPT for 4 h before and
during EDTA incubation.
Western blotting and antibodies. Cells were
lysed in lysis buffer Awith brief sonication, and
the protein concentration was determined us-
ing a BCA kit (Pierce). Twenty to 30g of total
protein per sample was analyzed by SDS-
PAGE/Western blot analysis. The following anti-
bodies were used in this study: anti-V1744 (Cell
Signaling Technology), anti-NCT (N1660,
Sigma), anti-PS1-NTF (Santa Cruz Biotech-
nology), anti-PS2-CTF antibodies B24.2 and
G2L [generous gifts fromDr. Bart De Strooper
(Herreman et al., 1999) and Dr. Taisuke To-
mita (Tomita et al., 1998), respectively], anti-
Aph1a (Covance), anti-Notch1 ANK domain
(mAN1) (Huppert et al., 2000), anti--actin
(Sigma), and anti-myc (9E10).
Results
NICD is generated in NCT/ cells but not in PSDKO cells
All GxGD proteases prefer substrates that have undergone
ectodomain shedding, and all, including PS, contain a substrate
recognition domain (Kornilova et al., 2005). We hypothesized
that if the role of NCTwas to stabilize -secretase, but not to bind
substrates, we should be able to detect -secretase activity in the
absence of NCT. To test this hypothesis, we transiently trans-
fected wild-type (NCTPW
/) and NCTPW
/ cells (from Dr.
P.C.Wong)with ectodomain-truncated,Notch1-expressing vec-
tor (pCS2/N1E-6MT). The truncated Notch1 E-6myc pro-
tein is a ligand-independent and direct substrate of -secretase,
similar to Notch extracellular truncation (NEXT) (Fig. 1A). To
enhance detection, transfected cells were cultured in the presence
of proteasome inhibitors that reduce the turnover of the NICD
(Tagami et al., 2008) and increase the sensitivity of detection for
this cleavage product. Western blot analyses with an anti-myc
antibody indicated that N1E-6MT expression levels in
NCTPW
/ and NCTPW
/ cells were equivalent and that pro-
teasome inhibition increased the amounts of N1E-6MT (Fig.
1B, lanes 2, 5, and 6), presumably by decreasing degradation of
uncleavedmolecules. Consistent with previous reports (Zhang et
al., 2005), we also observed PS1 N-terminal fragment (PS1-NTF)
in NCTPW
/ cells, an indication that some presenilinase activity
remained (Fig. 1B, lane 4). We then assessed N1E-6MT cleav-
age between G1743-V1744 with an epitope-specific antibody (-
VLLS; i.e., V1744 antibody). When probed with anti-V1744
antibody, NICD was detected in NCTPW
/ cells as expected.
Significantly, in the presence of proteasome inhibitors, PS1-NTF
and NICD accumulated in NCTPW
/ cells (Fig. 1B, lane 5). To
examine whether the NICD generated in NCTPW
/ cells was
produced by an aspartyl protease, we asked whether this NCT-
independent protease was sensitive to a selective -secretase
inhibitor (GSI), DAPT (N-[N-(3,5-difluorophenacetyl-L-
alanyl)]-S-phenylglycine t-butyl ester) (Weihofen et al., 2003).
DAPT completely abolished the generation of NICD in
NCTPW
/ cells (Fig. 1B, lane 6), suggesting that NICD is gener-
ated by a -secretase-like activity in the absence of NCT. Gener-
ation of NICD in NCTPW
/ cells was also blocked by a
structurally distinct GSI, L-685,458 (Fig. 1B, lane 14). We there-
fore concluded that in theNCTPW
/ cell line,Notch is cleaved at
the peptide bond between G1743 and V1744 [site 3 (S3)] by a
GSI-sensitive activity.
To our knowledge, -secretase is the only enzyme that cleaves
Notch1 at its S3 site, but the existence of other enzymes with
-secretase-like activity has been proposed to compensate for PS
loss (Huppert et al., 2005). To ask whether a Notch intramem-
brane protease exists in other -secretase-deficient cells, we ex-
amined NICD generation in PSDKO cells, which are deficient in
bothPS1 andPS2.Western blot analyses showed that bothPSDKO
and NCTPW
/ cells expressed high levels of N1E-6MT, yet
NICD was undetectable in samples from PSDKO cells under the
same conditions that allow NICD accumulation in NCTPW
/
samples (Fig. 1B, lanes 9 and 13). The generation of NICD in
PSDKO cells can be rescued by transfection of wild-type PS1 or
PS2 but not an inactive aspartyl mutant PS1, confirming that the
failure to generate NICD by PSDKO cells is not an indication of
other defects (supplemental Fig. 2, available at www.jneurosci.
org as supplementalmaterial) (Schroeter et al., 2003). Overall, these
results indicate that a -secretase-like activity in NCTPW
/ cells
cleaves Notch to generate NICD and that this activity does not exist
in PSDKO cells.
Generation of NICD is observed in two independent
NCT/ lines
We noticed a faint cross-reacting band with mobility similar to
that of immature NCT in NCTPW
/ cells (Fig. 1B). NCTPW
/
cells were derived from an NCT knock-out embryo in which the
critical part of the DAP (DYIGS and peptidase homologous re-
gion) domain (exon 9, intron 9, and part of exon 10)was replaced
Figure 2. Generation of NICD is observed in two independent NCT/ lines. Representative Western blots of NICD levels
generated in pCS2/N1E-6MT-transfectedNCTPW
/, NCTRR
/, NCTPW
/, and PS/ cells are shown. NICDwas detected
in both NCTPW
/ and NCTRR
/ lysates and was blocked by the -secretase inhibitor L-685,458. Because NCTRR
/ cells
express lessN1E-6MT comparedwithother cell lines, a longer exposurewasused for detectingNICD. The twowild-typeMEF lines
(NCTPW
/ and PS/) and wild-type MEFs isolated from littermates of NCTRR
/mice displayed similar -secretase activity
(lanes 5–8, 13–16, and data not shown). FL-PS1, Full-length PS1.
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with the neomycin resistance gene (Li et al., 2003). To test
whether -secretase-like activity in this specific cell line was due
to residual NCT expression, we analyzed a second, independently
generatedNCT knock-outmouse line (fromDr. Richard Rozma-
hel) in which exon 3 and a part of exon 4 had been deleted, and
therefore splicing downstream of the deletion would shift the read-
ing frame (Nguyen et al., 2006). We isolated NCTRR
/MEF cells
fromE9.5NCTRR
/ embryos and examinedNCTproduction and
-secretase activity in these cells. No NCT immunoreactivity was
observed in NCTRR
/ cell extracts (Fig. 2, lanes 9–12). Impor-
tantly, as in NCTPW
/ cells, endoproteolysis of PS1 in NCTRR
/
was also observed, confirming that PS endoproteolysis does not re-
quire NCT. Accordingly, in the presence of proteasome inhibitors
we observed NICD accumulation in NCTRR
/ cells (Fig. 2, lane
11). In this cell line, NICD production was again blocked by either
L-685,458 (Fig. 2, lane 12) or DAPT (Fig. 3A). Overall, these data
clearly demonstrate that generation of NICD by residual
-secretase-like activity is independent of
the specific NCT/ line used.
Endogenous Notch can be cleaved by
the -secretase-like activity in NCT/
cells but not in PSDKO cells
The -secretase-like activity that survived
removal of NCT may only cleave ectopi-
cally expressed Notch substrates lacking
an extracellular domain. To ask whether
this enzyme could cleave endogenous
Notch, we examined the cleavage of en-
dogenous Notch1 receptors under condi-
tions that induce ectodomain shedding at
the cell surface. In the absence of ligands, a
calcium-stabilized negative regulatory re-
gion prevents metalloprotease access to
the S2 cleavage site (Gordon et al., 2007).
Ligand binding or treatment with EDTA
(Rand et al., 2000) is thought to result in a
conformational change that leads to the
exposure of the S2 cleavage site and sub-
sequent cleavage by ADAM (a disintegrin
and metalloproteinase) metalloproteases
(Kopan and Ilagan, 2009), generating
NEXT (Fig. 1A), a direct substrate of
-secretase.Western blot analyses showed
that all the MEF lines (except for
NCTPW
/) expressed endogenous Notch1.
To test whether the generation of NICD
from endogenousNotch1 can occur with-
out NCT protein, PSDKO cells and
NCTPW
/, NCTRR
/, and wild-type
MEFs were treated with or without EDTA
to induce S2 cleavage (see shift inmobility
in Fig. 3A). Importantly, after treatment
with EDTA,DAPT-sensitiveNICDgener-
ation was detected in NCTRR
/ and
wild-type cells (Fig. 3A, lanes 8–9 and 11–
12).Moreover, after EDTA treatment, en-
dogenous NICD was observed in
NCT/ cells even without proteasome
inhibition (Fig. 3A,B). This result con-
firms that ectodomain shedding is re-
quired for the release of NICD in
NCTRR
/ cells (Fig. 3A, compare lanes 7
and 8). In contrast, Notch1-expressing PSDKO cells accumulated
the S2 cleavage product NEXT but did not produce NICD (Fig.
3A, lanes 1 and 2). Because removal of calciumwith EDTAoccurs
at or near the cell surface and because both ADAM10 andNotch1
aremainly localized at the plasmamembrane (van Tetering et al.,
2009), this result suggests that theNCT-deficient -secretase-like
protease performs its activity at or close to the plasmamembrane.
To obtain physiologically relevant evidence that -secretase-
like activity reached the cell surface, we askedwhether theNotch1
receptors in NCTRR
/ cells could be activated by ligands pre-
sented on neighboring cells. We cocultured NCTRR
/ (or con-
trol PSDKO cells) with either ligand-expressing (CHO-DLL1) or
control (CHO-GFP) cells in the presence or absence of protea-
some inhibitors. Western blot analysis shows that coculture with
CHO-DLL1 cells induced endogenous Notch1 S2 cleavage (Fig.
3B). As expected, if the enzyme reached the cell surface, endoge-
nous NICD was detected in NCTRR
/ cells cocultured with
Figure 3. NICD is generated from endogenous Notch1 in NCT/ cells but not in PS DKO cells. A, RepresentativeWestern blots
of NICD levels in EDTA-treated cells. Metalloprotease-mediated shedding occurs after calcium chelation-induced dissociation of
endogenous Notch1. EDTA treatment led to reduced amounts of furin-cleaved Notch [transmembrane/intracellular (TMIC)] and
increased amounts of NEXT, indicating that upon EDTA treatment Notch1 undergoes S2 site cleavage in PS DKO, NCTRR
/, and
PS/ cells. Although endogenous Notch1 levels are similar in both PS DKO and NCTRR
/ cells, NICD is produced from NEXT only
in NCTRR
/ (arrow) cells but not in PS DKO cells. NCTPW
/ cells do not express endogenous Notch1. B, Representative Western
blots of NICD levels in NCTRR
/ cells cocultured with Notch ligand-expressing cells. NICD is generated in NCTRR
/ cells from
endogenous Notch1 receptors after activation by ligands presented by neighboring cells. Note that NICD was only detected in
coculture of NCTRR
/ cells with CHO-DLL1 cells but not in the other cocultures or CHO cells alone. DAPT treatment blocked the
generation of NICD. Long Exp., Long exposure; Short Exp., short exposure.
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CHO-DLL1 (Fig. 3B, lanes 8 and 9) but
not in NCTRR
/ cells cocultured with
CHO-GFP. DAPT blocked the generation
of NICD in NCTRR
/ cells (Fig. 3B,
lane10), and PSDKO cells cocultured with
CHO-DLL1 cells did not release NICD,
indicating that NICD was not generated
by the CHO cells (Fig. 3B, lanes 4, 5, 11,
and 12). Together, these results confirm
that the -secretase-like activity in
NCT/ cells requires substrate ectodo-
main shedding and can reach the plasma
membrane to mediate the cleavage of
ligand-activated Notch.
C99 is converted into AICD and A in
NCT/ cells but not in PSDKO cells
Another important substrate of -secretase
is APP, which is involved in the pathogene-
sis of Alzheimer’s disease. Since mutations
in NCT were shown previously to differen-
tially affect APP and Notch processing
(Chen et al., 2001), we asked whether a
truncated APP substrate (C99) could be
processed inNCT/ cells by the-secretase-
likeactivity.WetransientlytransfectedPSDKO,
NCTPW
/, NCTRR
/, and wild-type MEF
cells withC99-6myc-expressing vector.West-
ern blot analyses confirmed that a DAPT-
sensitive fragment (AICD-6myc) present in wild-type cells but not in
PSDKO cellswas also seen in twoNCT-deficient cell lines (Fig. 4A, lanes
3, 7, and 13), suggesting that NCT/ cells are able to cleave C99 (Fig.
4A; note that proteasome inhibition was required to detect the
cleavage products). A longer exposure detected low amounts of
AICD-myc in NCTPW
/ cells not treated with proteasome in-
hibitors (supplemental Fig. 1, available at www.jneurosci.org as
supplemental material). To address whether A was also pro-
duced in NCT/ cells, we performed ELISA analysis on condi-
tionedmedia todetermine the secretedA levels.A40wasdetected
in conditionedmedia fromNCT/ cells but not from PSDKO cells
(Fig. 4B) andwas abolished afterDAPTaddition (Fig. 4B).Wewere
unable to detect A42 levels with the A42 ELISA kit, likely due to
the low transfection efficiency of MEF cells. Collectively, these data
indicate that not only can the residual -secretase activity cleave
APP, it can proceed from the -cleavage site to the -cleavage site, a
hallmark of -secretase (Tanzi and Bertram, 2005; Haass and
Selkoe, 2007), even in the absence of NCT.
-Secretase-like activity in NCT/ cells is PS1 dependent
The fact that two unrelated -secretase inhibitors abolished the
-secretase-like activity in NCT/ cell lines, and that PSDKO
cells did not exhibit this activity, strongly implies that PS is the
active enzyme in NCT/ cells. To test this, we used siRNAs to
knock down PS1 and PS2 (alone or together) in NCTRR
/ cells
transfected with N1E-6MT. Western blot analysis confirmed
that PS1 siRNA markedly decreased both full-length PS1 and
PS1-NTF (Fig. 5A, lanes 3 and 4), whereas control siRNA andPS2
siRNA did not affect PS1 protein level (Fig. 5A, lanes 1, 2, 5, and
6). Interestingly, PS1 knockdown alone was sufficient to signifi-
cantly diminish NICD production, whereas knockdown of PS2
did not show an obvious effect (Fig. 5A, lanes 5–6). Since we
could not detect PS2 in these cells with two different established
antibodies (Tomita et al., 1998; Herreman et al., 1999), the effi-
ciency of PS2 siRNA knockdown was confirmed by qRT-PCR
(Fig. 5B). Accordingly, cotransfection of PS1 siRNA together
with PS2 siRNA did not further reduce NICD amounts (Fig. 5A,
lanes 7 and 8). Similar results were obtainedwithNCTPW
/ cells
(supplemental Fig. 3, available at www.jneurosci.org as supple-
mental material). These results suggest that PS1 or a PS1-
containing enzyme in NCT/ cells mediates NICD production.
To ask whether PS2 can contribute to -secretase activity in
NCT/ cells, we overexpressed PS2 in NCTRR
/ cells. We first
performed PS1 mRNA knockdown and then asked whether co-
transfection of the substrate (pCS2/N1E-6MT) with either
human PS1 or PS2 expression vector into these mouse PS1-
depleted NCT/ cells would restore the -secretase activity.
While both PS1 and PS2 restored -secretase activity equally well
in PSDKO cells, only human PS1, but not human PS2, restored
-secretase activity in PS1 siRNA-transfectedNCT/ cells (sup-
plemental Fig. 2, available at www.jneurosci.org as supplemental
material). These data confirmed that PS2 protein could not con-
tribute to the -secretase activity in NCT/ cells.
Pen2 and Aph1a are involved in the -secretase-like activity
To ask whether PS1 acted as a single-molecule protease like SPP
(Golde et al., 2009), we examined whether Pen2 and Aph1 were
still required for the PS1 activity in the absence of NCT. We
performed Pen2 or Aph1 knockdown in NCTRR
/ cells using
siRNApools and confirmed the efficiencies of siRNAknockdown
by qRT-PCR (Fig. 6B,D). Western blot analyses demonstrated
that knockdown of Pen2 did not decrease the amount of full-
length PS1 but dramatically reduced PS1-NTF levels and, con-
comitantly, the amounts of NICD (Fig. 6A, lanes 3–8). Of the
three murine Aph1 genes (Ma et al., 2005; Serneels et al., 2005),
only knockdown of Aph1a in NCTRR
/ cells reduced PS1-NTF
and NICD levels, whereas full-length PS1 levels remained un-
changed (Fig. 6C, lanes 3–6). Aph1b siRNA did not impact PS1-
Figure 4. C99 is cleaved to generate AICD and A in NCT/ cells but not in PS DKO cells. A, Representative Western blots of
AICD levels in C99-6MT-transfected cells. PS DKO, NCTPW
/, NCTRR
/, and PS/ cells were transiently transfected with
pCS2/C99-6MT or empty vector and analyzed for AICD and A generation. A DAPT-sensitive AICD-6Myc band was observed in
NCT/ cells and wild-type MEFs but not in PS DKO cells. A -secretase-independent, faster-migrating Myc-reactive band was
observed in all samples (it was not sensitive to DAPT andwas generated in PS DKO cells). B, A40 is produced in NCT/ cells but
not in PS DKO cells. The CM from cells transfected with empty vector was used as the blank in the assay.
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NTF or NICD level (Fig. 6C, lanes 7–10). Similar results were
obtained with NCTPW
/ cells (supplemental Fig. 3, available at
www.jneurosci.org as supplemental material). These results sug-
gest that in NCT/ cells, an unstable -secretase isomorph
composed of three proteins (PS1, Pen2, and Aph1a) provides
-secretase activity that correlates strongly with the amount of
endoproteolytically processed PS1-NTF but not full-length PS1.
Thus, PS1 activity requires endoproteolysis and the functions of
Pen2 and Aph1a.
Trimeric -secretase retains 50% of the enzyme activity
To accurately evaluate the remaining -secretase activity in
NCT/ cells, we tried to establish a cell-free assay. However,
although we could readily detect -secretase activity in solubi-
lized membranes from wild-type cells, we failed to detect any
-secretase-like activity in solubilizedmembranes fromNCT/
cells (data not shown). It is likely that the trimeric -secretase
complex lackingNCT is highly unstable in the detergent solution,
as it was unstable in blue native gels (data not shown). Therefore,
we compared the relative activity of -secretase in NCT/ cells
andwild-type cells using a semiquantitativeWestern blot analysis
of extracts isolated from cells cultured in the presence of protea-
some inhibitors. As shown in supplemental Figure 4 (available at
www.jneurosci.org as supplemental material), in cell lysates con-
taining equivalent levels of PS1 NTF fragments, NCT/ cells
produced 50–55% of the NICD produced by wild-type lines.
From these data, we can conclude that the trimeric enzyme is
much more active than would be expected if NCT was providing
the substrate recognition function in the complex. We cannot
rule out an indirect contribution byNCT to overall activity due to
increased enzyme stability.
Discussion
PS, NCT, Pen2, and Aph1 are the four proteins essential for recon-
stituting robust -secretase activity (De Strooper, 2003; Iwatsubo,
2004; Spasic andAnnaert, 2008).With the exception of PS, which
harbors the catalytic site of -secretase, the precise contributions
of the other proteins to -secretase activity remain unclear, and
PS remains the only GxGD protease that requires partners for its
protease activity. Here, we have provided direct evidence that
when PS1/Pen2/Aph1a are present, -secretase can assemble and
acquire catalytic activity without NCT, cleaving both Notch and
APP (C99) substrates. Furthermore, this three-protein enzyme
remains biochemically similar to the four-protein enzyme: both
are DAPT and L-685,458 sensitive (Fig. 1B), both generate NICD
at the S3 site (Figs. 1–3), and both cleave APP at  and  to release
AICD and A40, respectively (Fig. 4). Importantly, ligand-
mediated activation of endogenousNotch can also be observed in
NCT/ cells (Fig. 3B). However, this residual activity is not
sufficient to permit survival of NCT/ embryos (Li et al., 2003;
Nguyen et al., 2006).
As this manuscript was being prepared, another group iden-
tified NCT-independent PS1 mutants (PS1 S438P or PS1 F411Y/
S438P) (Futai et al., 2009), suggesting that perhaps this S438P
mutation increased complex stability. We aligned PS proteins
with their homologues and found that a Pro residue is located at
a conserved position in TMD9 of SPP (P324; supplemental Fig. 5,
available at www.jneurosci.org as supplemental material), sug-
gesting that the-helix-breaking Pro residuemay increase stabil-
ity of GxGD proteases. Interestingly, this analysis revealed that
one of the two Caenorhabditis elegans PS proteins, Hop-1, also
contains a Pro at the homologous position (P329) whereas the
other (Sel-12) does not. Consistent with the hypothesis that
-secretase complexes centered aroundHop-1may have reduced
dependency on the Aph2/NCT gene (Goutte et al., 2000), Aph-
2/Hop-1 double mutants are strongly affected but Aph-2/Sel-12
doublemutants are not (Francis et al., 2002). This result indicates
that Hop-1 is active without Aph-2, whereas Sel-12 is dependent
onAph-2 for full activity.NCThas been proposed to play a role in
PS1 trafficking. In the absence of NCT,most PS1 proteins remain
in the endoplasmic reticulum; PS1-NTFs were undetectable at
the plasma membrane (Zhang et al., 2005). We have provided
indirect evidence that at least some PS1 NTF-containing
-secretase can reach the plasmamembrane where it can activate
a ligand-dependentNotch signal in the absence of NCT. Coupled
with the genetic data (Francis et al., 2002) andwith the analysis of
NCTmutants (Chavez-Gutierrez et al., 2008), these observations
favor amodel inwhichNCT acts to stabilize-secretase but is not
required for catalytic activity.
Although we cannot completely rule out the possibility that
NCT contributes to -secretase activity and that this contribu-
Figure 5. -Secretase-like activity in NCT/ cells is PS1 dependent. A, Representative
Western blots of NICD levels in PS siRNA-transfected NCTRR
/ cells. NCTRR
/ cells were
transfectedwith PS1, PS2, PS1-plus-PS2, or nontargeting control siRNAs. The cells were subse-
quently transfected with pCS2/N1E-6MT and cultured in the presence of proteasome in-
hibitors. Cell lysates were then analyzed by Western blotting with antibodies against PS1NT,
Myc, V1744, and -actin. PS1 siRNA markedly decreased both full-length PS1 (FL-PS1) and
PS1-NTF.Although the levels ofN1E-6mycare similar in every extract,NICDaccumulationwas
strikingly reduced in PS1 siRNA-transfected cells and in PS1-plus-PS2 siRNA-transfected cells
but not in siRNA control (Ctr)- or PS2 siRNA-transfected cells. B, Since the PS2 proteins in these
NCT/ cells were undetectable by Western blot analysis using two well-characterized anti-
PS2 antibodies (data not shown), knockdown of PS2 was confirmed by qRT-PCR.
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tion requires E333 (Dries et al., 2009), our findings indicate that
neither substrate recognition nor contribution to catalytic activ-
ity by NCT is necessary for -secretase activity. A distinct prop-
erty of -secretase-mediated intramembrane cleavage is that it
requires prior ectodomain shedding of the substrate; the large
extracellular domain of NCT has been proposed to act as the
gatekeeper that measures the size of the substrate ectodomain
and the availability of a free N terminus (Hu et al., 2002; De
Strooper, 2005; Shah et al., 2005). However, we found that NCT-
deficient-secretase activity still requires prior ectodomain shed-
ding of its substrates (Fig. 3) (Mumm et al., 2000). It is unlikely
that an unknown protein may function as NCT in NCT/ cells,
and no additional NCT homologues have been found in the
mouse or C. elegans genome. Indeed, a substrate-binding site has
also been identified at the interface of PS1 NTF/CTF (Kornilova
et al., 2005); this site may also be sensitive to the presence of a
large extracellular domain. Additionally, the GxGD motif in
PS has been reported to contribute to substrate identification
(Yamasaki et al., 2006). Furthermore, a PS relative, SPPLP2,
requires substrate shedding yet does not require putative sub-
strate binding partners (Martin et al., 2009).
How -secretase assembly occurs is a critical question in
-secretase biology. One model posits that PS binds initially to
Aph1 and NCT to form a subcomplex, and then this subcomplex
binds to Pen2 to initiate PS endoproteolysis and NCT glycosyla-
tion (Takasugi et al., 2003). Alternatively, PS and Pen2 form a
subcomplex in which PS endoproteolysis occurs while NCT and
Aph1 form another subcomplex. The two subcomplexes then
bind together (Spasic and Annaert, 2008). In both models,
-secretase activity is conferred only after the complete assembly
of the four-protein complex. The observations reported here sug-
gest that a trimeric complex containing PS1, Pen2, and Aph1a is
active but unstable and perhaps rapidly converted to the four-
protein complex in wild-type cells. Whether such a subcomplex
Figure 6. Pen2 and Aph1a are involved in the -secretase activity in the absence of NCT. Representative Western blots of NICD levels in Pen2 and Aph1 siRNA-transfected NCTRR
/ cells are
shown. A, Lysates from control (Ctr) siRNA- or Pen2 siRNA-transfected NCT/ cells were analyzed by Western blotting. Pen2 siRNAmarkedly decreased PS1-NTF level but not that of full-length
PS1 (FL-PS1). Whereas Pen2 depletion slightly affected N1E-6MT expression, it significantly diminished NICD generation in a dose-dependent manner. Note that the amounts of a PS1 fragment
(30 kDa) increased in Pen2 siRNA-treated samples. This PS1 fragment does not have-secretase activity.B, The efficiency of Pen2 knockdown (90%)was confirmed by qRT-PCR. C, Depletion
of Aph1a in NCTRR
/ cells markedly decreased PS1-NTF and NICD generation, whereas Aph1b siRNA treatment did not significantly affect NICD levels. D, Knockdown of Aph1b was confirmed by
qRT-PCR.
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occurs in the presence of NCT or only forms in its absence re-
mains to be determined.
Why PS proteins require additional stabilizing components
whereas SPP and SPPL do not and why PS2 is unable to act
without NCT are interesting puzzles still to be resolved. The fact
that -secretase activity could not be detected in PSDKO cells
(Figs. 1, 3, and 4) and that PS1 siRNA greatly diminished the
residual -secretase activity in NCT/ cells (Fig. 5A; supple-
mental Figs. 2 and 3, available at www.jneurosci.org as supple-
mental material for sequences) confirms the centrality of PS for
-secretase activity. Interestingly, although PS possesses both
substrate-binding and catalytic sites and thus has the potential to
act as an enzyme on its own, knockdown of Pen2 and Aph1a
eliminated -secretase activity in NCT/ cells (Fig. 6). Despite
establishing that PS requires these two proteins, the current data
cannot distinguish whether Pen2 and Aph1 are required for sta-
bilizing PS1 or for enhancing its catalytic activity. If Aph1 or Pen2
are required only to stabilize PS1, it is conceivable that other
unstable trimeric -secretase complexes can be formed in vitro. It
is intriguing to suggest that isolation of such an active trimeric
-secretase might facilitate the elucidation of its structure. It also
appears that active Hop-1 trimeric -secretase complexes may
exist in vivo and can be isolated from Aph-2 mutants.
In conclusion, the present data demonstrate that NCT is dis-
pensable for PS1-containing -secretase activity and cell surface
transport but critical for stabilizing -secretase. This study also
provides a biochemical explanation for the differential require-
ment for Aph2 shown by the two C. elegans PS proteins, Hop-1
and Sel-12.
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